RADIORECEPTOR ASSAY FOR QUANTIFYING FK-506 IMMUNOSUPPRESSANT IN WHOLE-BLOOD

被引:0
|
作者
MURTHY, JN
CHEN, YJ
WARTY, VS
VENKATARAMANAN, R
DONNELLY, JG
ZEEVI, A
SOLDIN, SJ
机构
[1] CHILDRENS NATL MED CTR,DEPT LAB MED,111 MICHIGAN AVE NW,WASHINGTON,DC 20010
[2] GEORGE WASHINGTON UNIV,SCH MED,DEPT PATHOL,WASHINGTON,DC 20052
[3] GEORGE WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20052
[4] GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20052
[5] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
[6] UNIV PITTSBURGH,SCH PHARM,PITTSBURGH,PA 15260
关键词
IMMUNOSUPPRESSIVE DRUGS; FK-506 BINDING PROTEIN; ANTIBIOTICS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We describe a quantitative radioreceptor assay (RRA) for quantifying FK-506 in whole blood. FK-506 extracted from whole blood with a cyclohexyl-sorbent column competes with [H-3]dihydro-FK-506 for binding to a partially purified preparation of FK-506 binding protein (FK-BP). Free and protein-bound FK-506 are separated on LH 20 Sephadex chromatographic columns. We compared the results of this method with those of an enzyme immunoassay that uses a monoclonal antibody: r = 0.97, S(y\x) = 0.039. Between-day precisions (CV) at FK-506 concentrations of 8 and 17-mu-g/L were 9.2% and 8.2%, respectively. Within-run precisions were 5.9%, 8.1%, and 9.4%, respectively, at 4, 8, and 15-mu-g/L. Analytical recovery, evaluated at 5, 10, 15, 20, and 25-mu-g/L for FK-506 added to whole blood, ranged from 98% to 103%. The assay can reliably quantify FK-506 blood concentrations between 1.0 and 25-mu-g/L.
引用
收藏
页码:1307 / 1310
页数:4
相关论文
共 50 条
  • [1] A WHOLE-BLOOD FK-506 ASSAY FOR THE IMX ANALYZER
    GRENIER, FC
    LUCZKIW, J
    BERGMANN, M
    LUNETTA, S
    MORRISON, M
    BLONSKI, D
    SHOEMAKER, K
    KOBAYASHI, M
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2748 - 2749
  • [2] STABILITY OF FK-506 IN WHOLE-BLOOD SAMPLES
    FREEMAN, DJ
    STAWECKI, M
    HOWSON, B
    THERAPEUTIC DRUG MONITORING, 1995, 17 (03) : 266 - 267
  • [3] FK-506 - MONITORING IN PLASMA OR IN WHOLE-BLOOD
    BEYSENS, AJ
    WIJNEN, RMH
    BEUMAN, GH
    VANDERHEYDEN, J
    KOOTSTRA, G
    VANAS, H
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2745 - 2747
  • [4] MONITORING FK-506 CONCENTRATIONS IN PLASMA AND WHOLE-BLOOD
    JUSKO, WJ
    DAMBROSIO, R
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2732 - 2735
  • [5] JAPANESE STUDY OF FK-506 ON KIDNEY-TRANSPLANTATION - THE BENEFIT OF MONITORING THE WHOLE-BLOOD FK-506 CONCENTRATION
    UCHIDA, K
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3085 - 3088
  • [6] FK-506, A NOVEL IMMUNOSUPPRESSANT
    KINO, T
    HATANAKA, H
    GOTO, T
    OKUHARA, M
    NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY, 1989, 63 (02): : 224 - 227
  • [7] FK-506 - A NOVEL IMMUNOSUPPRESSANT
    PARSONS, WH
    SIGAL, NH
    WYVRATT, MJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 : 22 - 36
  • [8] FK-506 - A NOVEL IMMUNOSUPPRESSANT
    MACLEOD, AM
    THOMSON, AW
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1990, 10 (03): : 329 - 332
  • [9] STABILITY OF TACROLIMUS (FK-506) AND CYCLOSPORINE-G IN WHOLE-BLOOD
    ANNESLEY, TM
    HUNTER, BC
    FIDLER, DR
    GIACHERIO, DA
    THERAPEUTIC DRUG MONITORING, 1995, 17 (04) : 361 - 365
  • [10] TOTAL SYNTHESIS OF THE IMMUNOSUPPRESSANT (-)-FK-506
    JONES, TK
    MILLS, SG
    REAMER, RA
    ASKIN, D
    DESMOND, R
    VOLANTE, RP
    SHINKAI, I
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (03) : 1157 - 1159